Increased thrombin generation in inflammatory bowel diseases

Thrombosis Research

Volumn 125, Issue 3, 2010, Pages 278-282

  Saibeni, Simone ^a   Saladino, Valeria ^b   Chantarangkul, Veena ^b   Villa, Federica ^b   Bruno, Savino ^a   Vecchi, Maurizio ^c   de Franchis, Roberto ^b   Sei, Cinzia ^b   Tripodi, Armando ^b  

^a FATEBENEFRATELLI HOSPITAL   (Italy)

^b MAGGIORE HOSPITAL   (Italy)

^c IRCCS POLICLINICO SAN DONATO   (Italy)

Author keywords

Inflammation; Inflammatory bowel diseases; Thrombin generation

Indexed keywords

C REACTIVE PROTEIN; PHOSPHOLIPID; THROMBOMODULIN; THROMBOPLASTIN;

ADULT; ARTICLE; BLOOD CLOTTING; BLOOD CLOTTING PARAMETERS; BLOOD SAMPLING; CONTROLLED STUDY; CROHN DISEASE; ENDOGENOUS THROMBIN POTENTIAL; FEMALE; HUMAN; HYPERCOAGULABILITY; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; THROMBIN TIME; ULCERATIVE COLITIS;

ADULT; C-REACTIVE PROTEIN; CASE-CONTROL STUDIES; COLITIS, ULCERATIVE; CROHN DISEASE; FACTOR VIII; FEMALE; HUMANS; INFLAMMATORY BOWEL DISEASES; MALE; MIDDLE AGED; PHOSPHOLIPIDS; PROSPECTIVE STUDIES; THROMBIN; THROMBOMODULIN; THROMBOPLASTIN;

EID: 77149154985     PISSN: 00493848     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.thromres.2009.10.012     Document Type: Article

References (40)

1. Miehsler W., Reinisch W., Valic E., Osterode W., Tillinger W., Feichtenschlager T., et al. Is inflammatory bowel disease an independent and disease specific risk factor for thromboembolism?. Gut 53 (2004) 542-548
2. Bernstein C.N., Blanchard J.F., Houston D.S., and Waida A. The incidence of deep venous thrombosis and pulmonary embolism among patients with inflammatory bowel disease: A population-based cohort study. Thromb Haemost 85 (2001) 430-434
3. Huerta C., Johansson S., Wallander Ma., and Garcia Rodriquez L.A. Risk factors and short-term mortality of venous thromboembolism diagnosed in the primary care setting in the United Kingdom. Arch Intern Med 167 (2007) 935-943
4. Ha C., Magowan S., Accortt N.A., Chen J., and Stone C.D. Risk of arterial thrombotic events in inflammatory bowel disease. Am J Gastroenterol 104 (2009) 1445-1451
5. Quera R., and Shanahan F. Thromboembolism - An important manifestation of inflammatory bowel disease. Am J Gastroenterol 99 (2004) 1971-1973
6. Grip O., Svensson P.J., and Lindgren S. Inflammatory bowel disease promotes venous thrombosis earlier in life. Scand J Gastroenterol 35 (2000) 619-623
7. Nguyen G.C., and Sam J. Rising prevalence of venous thromboembolism and its impact on mortality among hospitalized inflammatory bowel disease patients. Am J Gastroenterol 103 (2008) 2272-2280
8. Webberly M.J., Hart M., and Melikian V. Thromboembolism in inflammatory bowel disease: role of platelets. Gut 34 (1993) 247-251
9. Hudson M., Chitolie A., Hutton R.A., Smith M.S., Pounder R.E., and Wakefield A.J. Thrombotic vascular risk factors in inflammatory bowel disease. Gut 38 (1996) 733-737
10. van Bodegraven A.A., Schoorl M., Baak J.P., Linskens R.K., Bartels P.C., and Tuynman H.A. Hemostatic imbalance in active and quiescent ulcerative colitis. Am J Gastroenterol 96 (2001) 487-493
11. Cattaneo M., Vecchi M., Zighetti M.L., Saibeni S., Martinelli I., Omodei P., et al. High prevalence of hyperchomocysteinemia in patients with inflammatory bowel disease: A pathogenic link with thromboembolic complications?. Thromb Haemost 80 (1998) 542-545
12. Saibeni S., Vecchi M., Valsecchi C., Faioni E.M., Razzari C., and de Franchis R. Reduced free protein S levels in patients with inflammatory bowel disease: prevalence, clinical relevance, and role of anti-protein S antibodies. Dig Dis Sci 46 (2001) 637-643
13. Mann K.G. Thrombin formation. Chest 124 Suppl 3 (2003) 4S-10S
14. Dahlback B. Progress in the understanding of the protein C anticoagulant pathway. Int J Hematol 79 (2004) 109-116
15. Huntington J.A. Mechanisms of glycosaminoglycan activation of the serpins in hemostasis. J Thromb Haemost 1 (2003) 1535-1549
16. Tripodi A, Chantarangkul V, Mannucci PM. Acquired coagulation disorders: revisited using global coagulation/anticoagulation testing. Br J Haematol 2009;147:77-82.
17. Hemker H.C., Al Dieri R., De Smedt E., and Béguin S. Thrombin generation, a function test of the haemostatic-thrombotic system. Thromb Haemost 96 (2006) 553-561
18. Tripodi A., Salerno F., Chantarangkul V., Clerici M., Cazzaniga M., Primignani M., et al. Evidence of normal thrombin generation in cirrhosis despite abnormal conventional coagulation tests. Hepatology 4 (2005) 553-558
19. Vrij A.A., Oberndorff-Klein-Woolthuis A., Dijkstra G., de Jong A.E., Wagenvoord R., Hemker H.C., et al. Thrombin generation in mesalazine refractory ulcerative colitis and the influence of low molecular weight heparin. J Thromb Thrombolysis 24 (2007) 175-182
20. Best W.R., Becktel J.M., Singleton J.W., and Kern Jr. F. Development of a Crohn's disease activity index. Gastroenterol 70 (1976) 439-444
21. Truelove S.C., and Witts L.J. Cortisone in ulcerative colitis: final report of a therapeutic trial. BMJ 2 (1955) 1041-1048
22. Gasche C., Scholmerich J., Brynskov J., D'Haens G., Hanauer S.B., Irvine E.J., et al. A simple classification of Crohn's disease: report of the Working Party for the World Congress of Gastroenterology, Vienna 1998. Inflamm Bowel Dis 6 (2000) 8-15
23. Tripodi A., Chantarangkul V., Martinelli I., Bucciarelli P., and Mannucci P.M. A shortened activated partial thromboplastin time is associated with the risk of venous thromboembolism. Blood 104 (2004) 3631-3634
24. Hemker H.C., Wielders S., Kessels H., and Béguin S. Continuous registration of thrombin generation in plasma, its use for the determination of the thrombin potential. Thromb Haemost 70 (1993) 617-624
25. Chantarangkul V., Clerici M., Bressi A., Giesen P.L., and Tripodi A. Thrombin generation assessed as endogenous thrombin potential (ETP) in patients with hypo- or hyper-coagulability. Haematologica 88 (2003) 547-554
26. Bargen J.A., and Barker N.W. Extensive arterial and venous thrombosis complicating chronic ulcerative colitis. Arch Int Med 58 (1936) 17-31
27. van Bodegraven A.A. Haemostasis in inflammatory bowel diseases: clinical relevance. Scand J Gastroenterol 38 Suppl 239 (2003) 51-62
28. Tripodi A., Primignani M., Chantarangkul V., Clerici M., Dell'Era A., Fabris F., et al. Thrombin generation in patients with cirrhosis: the role of platelets. Hepatology 44 (2006) 440-445
29. Tripodi A., Martinelli I., Chantarangkul V., Battaglioli T., Clerici M., and Mannucci P.M. The endogenous thrombin potential and the risk of venous thromboembolism. Thromb Res 121 (2007) 353-359
30. Dielis A.W., Castoldi E., Spronk H.M., van Oerle R., Hamulyák K., Ten Cate H., et al. Coagulation factors and the protein C system as determinants of thrombin generation in a normal population. J Thromb Haemost 6 (2008) 125-131
31. Vecchi M., Sacchi E., Saibeni S., Meucci G., Tagliabue L., Duca F., et al. Inflammatory bowel diseases are not associated with major hereditary conditions predisposing to thrombosis. Dig Dis Sci 45 (2000) 1465-1469
32. Papa A., Danese S., Grillo A., Gasbarrini G., and Gasbarrini A. Review article: inherited thrombophilia in inflammatory bowel disease. Am J Gastroenterol 98 (2003) 1247-1251
33. Spina L., Saibeni S., Battaglioli T., Peyvandi F., de Franchis R., and Vecchi M. Thrombosis in inflammatory bowel diseases role of inherited thrombophilia. Am J Gastroenterol 100 (2005) 2036-2041
34. Lee L.C., Spittell Jr. J.A., Sauer W.G., Owen Jr. C.A., and Thompson Jr. J.H. Hypercoagulability associated with chronic ulcerative colitis: changes in blood coagulation factors. Gastroenterology 54 (1968) 76-85
35. Lake A.M., Stauffer J.Q., and Stuart M.J. Hemostatic alterations in inflammatory bowel disease: response to therapy. Am J Dig Dis 23 (1978) 897-902
36. Knot E., Ten Cate J.W., Leeksma O.C., Tytgat G.N., and Vreeken J. No evidence for a prethrombotic state in stable chronic inflammatory bowel disease. J Clin Pathol 36 (1983) 1387-1390
37. Mahmood A., Needham J., Prosser J., Mainwaring J., Trebble T., Mahy G., et al. Prevalence of hyperhomocysteinaemia, activated protein C resistance and prothrombin gene mutation in inflammatory bowel disease. Eur J Gastroenterol Hepatol 17 (2005) 739-744
38. Gabay C., and Kushner B. Acute-phase proteins and other systemic responses to inflammation. New Engl J Med 340 (1999) 448-454
39. Stouthard J.M., Levi M., Hack C.E., Veenhof C.H., Romijn H.A., Sauerwein H.P., et al. Interleukin-6 stimulates coagulation, not fibrinolysis, in humans. Thromb Haemost 76 (1996) 738-742
40. Danese S., Papa A., Saibeni S., Repici A., Malesci A., and Vecchi M. Inflammation and coagulation in inflammatory bowel disease: the clot thickens. Am J Gastroenterol 102 (2007) 174-186